FDA inspection
The Procter & Gamble Manufacturing Company: FDA inspection ending Aug 28, 2002
FDA inspection 233825 · No Action Indicated (NAI) · Phoenix, AZ
Key facts
| Inspection ID | 233825 |
|---|---|
| Firm | The Procter & Gamble Manufacturing Company |
| FEI number | 2021299 |
| Address | 2050 S 35th Ave |
| City | Phoenix |
| State | AZ |
| ZIP | 85009-6705 |
| Fiscal year | 2002 |
| Inspection end date | Aug 28, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data